(Q34065731)

30 July 2017

title

A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo (English)

1 reference

30 July 2017

1 reference

Jinpiao Lin

1

1 reference

30 July 2017

Rongfen Huo

2

1 reference

30 July 2017

Li Wang

3

1 reference

30 July 2017

Zhou Zhou

4

1 reference

30 July 2017

Yue Sun

5

1 reference

30 July 2017

Baihua Shen

6

1 reference

30 July 2017

Rongfang Wang

7

1 reference

30 July 2017

Ningli Li

8

1 reference

30 July 2017

publication date

3 November 2011

1 reference

Cancer Immunology, Immunotherapy

30 July 2017

published in

1 reference

30 July 2017

volume

61

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

677-687

1 reference

https://scigraph.springernature.com/pub.10.1007/s00262-011-1135-y

30 July 2017

exact match

0 references

cites work

The CCN family of proteins: structure-function relationships

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

The CCN family: a new stimulus package

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

All in the CCN family: essential matricellular signaling modulators emerge from the bunker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

A critical role of Cyr61 in interleukin-17-dependent proliferation of fibroblast-like synoviocytes in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Extracellular matrix associated protein CYR61 is linked to prostate cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

A sticky situation: CCN1 promotes both proliferation and apoptosis of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

CYR61 stimulates human skin fibroblast migration through Integrin alpha vbeta 5 and enhances mitogenesis through integrin alpha vbeta 3, independent of its carboxyl-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Cyr61 promotes breast tumorigenesis and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Alternative splicing of Cyr61 is regulated by hypoxia and significantly changed in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Cyr61 expression confers resistance to apoptosis in breast cancer MCF-7 cells by a mechanism of NF-kappaB-dependent XIAP up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

CYR61 and alphaVbeta5 integrin cooperate to promote invasion and metastasis of tumors growing in preirradiated stroma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Activation of host wound responses in breast cancer microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Targeting matrilysin and its impact on tumor growth in vivo: the potential implications in breast cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Caveolin-1 regulates the secretion and cytoprotection of Cyr61 in hyperoxic cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

The modular architecture of a new family of growth regulators related to connective tissue growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Identification of a Novel Integrin αMβ2 Binding Site in CCN1 (CYR61), a Matricellular Protein Expressed in Healing Wounds and Atherosclerotic Lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Alternative splicing of CCN mRNAs .... it has been upon us.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Challenges in the endocrine management of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Tumor self-seeding by circulating cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Cyr61 is overexpressed in gliomas and involved in integrin-linked kinase-mediated Akt and beta-catenin-TCF/Lef signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Ovarian carcinomas: CCN genes are aberrantly expressed and CCN1 promotes proliferation of these cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Invasion and MMP expression profile in desmoid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Proteolysis of CCN1 by plasmin: functional implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Genes that mediate breast cancer metastasis to lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Genes that mediate breast cancer metastasis to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

Activation of p38 and JNK MAPK pathways abrogates requirement for new protein synthesis for phorbol ester mediated induction of select MMP and TIMP genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-011-1135-Y

10.1007/S00262-011-1135-Y

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

30 July 2017

1049201300

0 references

1 reference